World

FDA approval of Biogen’s Alzheimer’s drug leaves some ‘disappointed’

Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button